Poliovirus Sabin 1 strain has its own special features that make it a particularly attractive live
recombinant mucosal vaccine vehicle. Sabin 1 cDNA was manipulated to have multiple …

Recombinant BCGs (rBCGs) containing extrachromosomal plasmids with different HIV-1
insert sequences: nef, env (V3J1 and E9Q), gag p17 or whole gag p55 were evaluated for …

Objective: To develop an effective therapeutic double HBV DNA vaccine with two eukaryotic
expressing motif, namely pS2. S and pIIF, a fusion ORF of hIL-2/hIFN-?. Methods: Two …

The studies for the development of transgenic mice models which provide important profits
for the studies concerning immunopathogenesis of hepatitis B virus (HBV) infections are in …

We attempted to develop a candidate HIV/AIDS vaccine, by using unprocessed HIV-2 gag
pr45 precursor protein. We found that a 45 kDa unprocessed HIV-2 gag precursor protein …

This unit describes a method for in vivo delivery of oligonucleotides or plasmids using the
hemagglutinating virus of Japan envelope (HVJ‐E), an inactivated Sendai virus particle, as …

To develop an effective therapeutic HBV DNA vaccine, two eukaryotic expressing plasmids,
namely pcDNAS 2? S and pcDNAIIF, which respectively encoding HBV middle envelope …

Lentiviral vectors are promising candidates for vaccination since they are capable of stably
transducing antigen presenting cells and generating a strong, specific and protective …

The hemagglutinating virus of Japan (HVJ; also called the Sendai virus) envelope has been
developed as a safe and efficient non‐viral vector. Because replication and transcription of …